Bionano Genomics, Inc.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2020 | $16.3M | $35.1M | $38.4M |
| FY2021 | $0 | $337.1M | $24.6M |
| FY2022 | — | $249.4M | $5.1M |
| FY2023 | — | $96.2M | $17.9M |
| FY2024 | — | $35.4M | $9.2M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2020 | $16.3M | $35.1M | $38.4M |
| FY2021 | $0 | $337.1M | $24.6M |
| FY2022 | — | $249.4M | $5.1M |
| FY2023 | — | $96.2M | $17.9M |
| FY2024 | — | $35.4M | $9.2M |